Literature DB >> 16436006

Diffuse large B cell lymphoma (DLBCL) in Pakistan: an emerging epidemic?

Muhammad Bilal Abid1, Faria Nasim, Kashif Anwar, Shahid Pervez.   

Abstract

There has been a recent concern among oncological clinicians and pathologists of our region regarding the disproportionate increase in the number of patients presenting with diffuse large B cell lymphoma (DLBCL). This prompted us to conduct a thorough, hospital-based epidemiological study in a major referral center of Pakistan. A total of 780 specimens were collected over last half decade from cases classified as adult Non Hodgkin's lymphoma (NHL). Out of these 780, 596 (76.4 %) were diagnosed as DLBCLs. The gender ratio was 2.3:1 (M:F) and the median age was 47.2 years, with an age range of 15-85 years. Nodal-NHLs constituted 42.2 % of all adult NHLs, with the cervical lymph nodes as the most frequent nodal site of presentation. The most frequent extranodal site was the gastro-intestinal tract (GIT), followed by the head and neck. In conclusion, we document an astonishingly high number of DLBCL amounting to an emerging epidemic in Pakistan, with a consideration of probable etiopathogenetic factors.

Entities:  

Mesh:

Year:  2005        PMID: 16436006

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  14 in total

1.  Extreme exigency in the extremity: an illustrative case of diffuse large B-cell lymphoma occurring in the arm.

Authors:  Muhammad Bilal Abid; Shi Wang; Hoi Yin Loi; Esther Hian Li Chan; Li Mei Poon; Sanjay de Mel
Journal:  Singapore Med J       Date:  2018-07       Impact factor: 1.858

2.  BCL2/Ki-67 index predict survival in germinal center B-cell-like diffuse large B-cell lymphoma.

Authors:  Yun-Long Tang; Yan Zhou; Ling-Ling Cheng; Yong-Zhong Su; Chun-Bin Wang
Journal:  Oncol Lett       Date:  2017-07-15       Impact factor: 2.967

3.  Clinicopathological Spectrum of Hodgkin's and Non-Hodgkin's Lymphoma: A Tertiary Care Cancer Hospital Study in Pakistan.

Authors:  Wardah Aslam; Maryam Habib; Saeeda Aziz
Journal:  Cureus       Date:  2022-06-03

4.  Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma.

Authors:  Xueling Ge; Xiao Lv; Lili Feng; Xiaoqian Liu; Junming Gao; Na Chen; Xin Wang
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

5.  Enhancing effects of indirubin on the arsenic disulfide-induced apoptosis of human diffuse large B-cell lymphoma cells.

Authors:  Ling Wang; Xianglu Li; Xinyu Liu; Kang Lu; N A Chen; Peipei Li; Xiao Lv; Xin Wang
Journal:  Oncol Lett       Date:  2015-02-09       Impact factor: 2.967

6.  Effects of 17-DMAG on diffuse large B-cell lymphoma cell apoptosis.

Authors:  Jia-Jia Li; Jing-Jing Zhang; Xiu Wang; Zi-Min Sun
Journal:  Exp Ther Med       Date:  2017-08-22       Impact factor: 2.447

7.  Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP.

Authors:  Zhi-Ming Li; Jia-Jia Huang; Yi Xia; Jian Sun; Ying Huang; Yu Wang; Ying-Jie Zhu; Ya-Jun Li; Wei Zhao; Wen-Xiao Wei; Tong-Yu Lin; Hui-Qiang Huang; Wen-Qi Jiang
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

8.  Non-Hodgkin Lymphoma (NHL) in Pakistan.

Authors:  Shahid Pervez
Journal:  Int J Mol Cell Med       Date:  2012

9.  A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution.

Authors:  Jia-Jia Huang; Yi Xia; Yu Wang; Pan-Pan Liu; Xi-Wen Bi; Peng Sun; Tong-Yu Lin; Wen-Qi Jiang; Zhi-Ming Li
Journal:  Oncotarget       Date:  2016-07-05

10.  The Frequency of Double Expresser in Selected Cases of High Grade Diffuse Large B-Cell Lymphomas.

Authors:  Maria Naseem; Muhammad Asif; Muhammad Tahir Khadim; Hafeez Ud-Din; Shahid Jamal; Iman Shoaib
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.